DailyMed
|
Other
|
FDA
|
NLM
|
2005
|
|
Data Mining on FDA's 510K Documents for Laboratory Tests
|
Research Initiative
|
FDA
|
NLM
|
2009
|
|
Demand Reduction Interagency Working Groups
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A
|
Research Initiative
|
FDA
|
NIAID, NINDS
|
2010
|
|
DHHS Behavioral Health Coordinating Committee Pharmaceutical Abuse Subcommittee Surveillance Report Team
|
Committee/ Workgroup
|
CDC, FDA, OS, SAMHSA
|
NIDA
|
2011
|
|
DHHS Childhood Overweight and Obesity Prevention Council
|
Public Education Campaign
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NIDDK
|
2008
|
|
DHHS Women's Health and the Environment Interagency Committee
|
Committee/ Workgroup
|
ATSDR, CDC, FDA, HRSA, IHS, OS
|
NCI, NICHD, OD
|
2000
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Committee/ Workgroup
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
CSR, NCCAM, NCATS, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD
|
1974
|
|
Dietary Supplements Federal Workgroup
|
Committee/ Workgroup
|
AHRQ, CDC, FDA, HRSA, SAMHSA
|
NCCAM, NCI, NCATS, NHLBI, NIDDK, NIEHS
|
2008
|
|
Dietary Supplements Ingredient Database (DSID)
|
Database
|
CDC, FDA
|
NCI, OD
|
2002
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of Drug Enforcement Administration (DEA) Scheduling Recommendations to the FDA
|
Research Initiative
|
FDA, OS
|
NIDA
|
Unknown
|
|
Dominantly Inherited Alzheimer’s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset Dominantly Inherited Alzheimer’s Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee/ Workgroup
|
FDA
|
NIDDK
|
2003
|
|
|